Variations in organism-specific severe sepsis mortality in the United States: 1999-2008
- PMID: 25230374
- DOI: 10.1097/CCM.0000000000000555
Variations in organism-specific severe sepsis mortality in the United States: 1999-2008
Abstract
Objective: Recent studies have reported decreased overall severe sepsis mortality, but associations with organism trends have not yet been investigated. This study explored organism-specific severe sepsis mortality trends from 1999 to 2008 in a large hospital-based administrative database.
Design: Secondary data analysis using the Nationwide Inpatient Sample.
Setting: United States hospitals sampled in the Nationwide Inpatient Sample dataset.
Patients: This sample approximates a stratified 20% sample of all nonfederal, short-term, general, and specialty hospitals serving adults in the United States. Severe sepsis hospitalizations and organism-specific causes were identified using predetermined International Classification of Diseases, 9th Revision, Clinical Modification codes.
Interventions: None.
Measurements and main results: Analysis was conducted using descriptive Cox proportional hazards and linear regression trend analysis. Adjustments were made for the influence of demographics, comorbidities, number of organisms, and number of organ failures on hospital mortality. The data for 5,033,257 severe sepsis hospitalizations were examined and revealed decreased in-hospital mortality from 40.0% to 27.8% during the study period. The leading cause of severe sepsis was 51.5% Gram-negative bacteria, followed by 45.6% Gram-positive, 1.7% anaerobic, and 1.2% fungal species. The most common Gram-negative organisms were 39.9% Escherichia coli and 17.6% Pseudomonas. Staphylococcus species (62.2% methicillin-sensitive Staphylococcus aureus and 22.6% Streptococcus) were the most commonly reported Gram-positive organisms. Crude mortality estimates were higher for anaerobic and fungal organisms, 34.5% and 31.4%, respectively. Among Gram-positive bacteria, mortality was highest for methicillin-sensitive S. aureus, 30.9%, whereas Pseudomonas was associated with the highest mortality for Gram-negative septicemia cases, 29.5%. After adjusting for covariates, anaerobes were associated with the highest mortality hazard of 1.31 (95% CI, 1.23-1.40). Methicillin-resistant S. aureus had the highest mortality hazard of 1.38 (1.33-1.44) for Gram-positive organisms, whereas all Gram-negative bacteria had decreased mortality hazards.
Conclusions: We not only confirmed an overall decline in severe sepsis mortality from 1999 to 2008 but also identified previously unreported variations in organism-specific severe sepsis mortality. Gram-negative organisms predominate, whereas anaerobes and methicillin-resistant S. aureus are significant predictors of mortality. Future clinical trials exploring new treatments in severe sepsis should incorporate individual organism trends to elucidate potential effect on mortality.
Comment in
-
Elucidating the known unknowns of sepsis.Crit Care Med. 2015 Jan;43(1):237-8. doi: 10.1097/CCM.0000000000000663. Crit Care Med. 2015. PMID: 25514712 No abstract available.
Similar articles
-
Trends in the epidemiology of pediatric severe sepsis*.Pediatr Crit Care Med. 2013 Sep;14(7):686-93. doi: 10.1097/PCC.0b013e3182917fad. Pediatr Crit Care Med. 2013. PMID: 23897242
-
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.Clin Infect Dis. 2004 Aug 1;39(3):309-17. doi: 10.1086/421946. Epub 2004 Jul 15. Clin Infect Dis. 2004. PMID: 15306996
-
The microbiology and outcome of sepsis in Victoria, Australia.Epidemiol Infect. 2006 Apr;134(2):307-14. doi: 10.1017/S0950268805004796. Epidemiol Infect. 2006. PMID: 16490135 Free PMC article.
-
Clinical challenges and unmet needs in the management of complicated skin and skin structure, and soft tissue infections.Surg Infect (Larchmt). 2005;6 Suppl 2:S-23-36. Surg Infect (Larchmt). 2005. PMID: 23577495 Review.
-
Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*.Crit Care Med. 2014 Mar;42(3):625-31. doi: 10.1097/CCM.0000000000000026. Crit Care Med. 2014. PMID: 24201173 Free PMC article. Review.
Cited by
-
Epidemiology of sepsis in a Japanese administrative database.Acute Med Surg. 2023 Oct 12;10(1):e890. doi: 10.1002/ams2.890. eCollection 2023 Jan-Dec. Acute Med Surg. 2023. PMID: 37841963 Free PMC article. Review.
-
Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria.Nat Commun. 2023 Mar 18;14(1):1530. doi: 10.1038/s41467-023-37200-w. Nat Commun. 2023. PMID: 36934086 Free PMC article.
-
Broad protective vaccination against systemic Escherichia coli with autotransporter antigens.PLoS Pathog. 2023 Feb 17;19(2):e1011082. doi: 10.1371/journal.ppat.1011082. eCollection 2023 Feb. PLoS Pathog. 2023. PMID: 36800400 Free PMC article.
-
Evaluation of an extracorporeal ozone-based bactericide system for the treatment of Escherichia coli sepsis.Intensive Care Med Exp. 2022 Apr 25;10(1):14. doi: 10.1186/s40635-022-00443-w. Intensive Care Med Exp. 2022. PMID: 35467176 Free PMC article.
-
Importance of early diagnosis and surgical treatment of calcified amorphous tumor-related native valve endocarditis caused by Escherichia coli: a case report.BMC Infect Dis. 2022 Mar 7;22(1):226. doi: 10.1186/s12879-022-07220-w. BMC Infect Dis. 2022. PMID: 35255861 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
